Financial Management Professionals »

Keros Therapeutics shares owned by Financial Management Professionals

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Financial Management Professionals from 13F filings

Historical chart of Financial Management Professionals investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Financial Management Professionals consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Financial Management Professionals

Quarter filed Position value Share count Share price at filing
2025-12-31 $29k 1.4k 20.36

More positions owned by Financial Management Professionals

Goldman Sachs Actvbeta US LRG ETF Etf (GSLC)
Dimensional Intern Core EQT MKT ETF Etf (DFAI)
Schwab US Large Cap Growth ETF Etf (SCHG)
Schwab US Large Cap ETF Etf (SCHX)
John Hancock Multifctr Mid CP ETF Etf (JHMM)
Goldman Sachs Actvbt International Equity ETF Etf (GSIE)
iShares Russell 1000 ETF IV Etf (IWB)
Vanguard S&P 500 ETF Etf (VOO)
iShares MSCI USA Multifct ETF Etf (SMLF)
Vanguard Total Bond Market ETF Etf (BND)
iShares Core MSCI Emerging ETF Etf (IEMG)
Vanguard Value ETF Stock (VTV)
Vanguard Large Cap ETF Etf (VV)
SPDR BLMBG SRT TR Int TRY BND ETF Etf (BWZ)
PIMCO 0-5 Year High YLD BND Idx ETF Etf (HYS)

View all positions for Financial Management Professionals

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics